Publication | Open Access
Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases
29
Citations
9
References
2010
Year
Medicinal ChemistryHealth SciencesMedicineRational Drug DesignAnti-cancer AgentDrug DevelopmentOther KinasesPharmacologyRadiation OncologyDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1